Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial
2026 · European Heart Journal · 0 citations
https://doi.org/10.1093/eurheartj/ehag073
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
362
Citations
7
h-index
6
i10-index
Anna Laura Herzog is an academic researcher from Universitätsklinikum Würzburg. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & COVID-19 Clinical Research Studies & Renal Diseases and Glomerulopathies. The author has an h-index of 7, co-authored 24 publications.
ORCID: 0000-0002-1767-8964Click to start Chat